“Critical” Drug List Would Be Created Under Shortages Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft bill being developed by Rep. John Carney, D-Del., also would create system to notify the public and other manufacturers of pending shortages.
You may also be interested in...
Shortage Notification May Have Legislative Momentum Again After BIO Questions Reimbursement Fix
Preventing shortages through increased communications with manufacturers could gain the upper hand in part because creating economic incentives may prove too difficult and controversial.
“Comprehensive” Drug Shortage Mitigation Bill Under Development In House
Like the Senate proposal, it could include reimbursement rate adjustments in addition to requiring early notification of shortages by manufacturers, but questions remain about ensuring there are no unintended consequences.
FDA’s Drug Shortage Prevention Tally: 96 Saves In Six Weeks
At Senate hearing, the agency says an executive order has helped spur notifications, while the GAO suggests Congress require manufacturers to tell FDA about anything that could affect the drug supply. Reimbursement changes will not solve the shortage problem, an HHS official argues.